From July 1, 2022 to September 30, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 42,941 shares, representing 0.29% for KRW 1,521.88 million under the buyback announced on December 10, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,170 KRW | +0.06% | -1.55% | +0.41% |
1st Jan change | Capi. | |
---|---|---|
+0.41% | 185M | |
+21.25% | 43.92B | |
+23.16% | 23.09B | |
+19.25% | 15.35B | |
+13.60% | 13.61B | |
+47.82% | 12.02B | |
-10.04% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.6B |
- Stock Market
- Equities
- A271980 Stock
- News Jeil Pharmaceutical Co.,Ltd
- Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.